MERCAPTOPURINE

MERCAPTOPURINE was reported 17430 times

MERCAPTOPURINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN BOCAVIRUS INFECTION 130 0.6878
1 HCOV-HKU1 INFECTION 11 0.5238
2 LYMPHOID TISSUE HYPOPLASIA 77 0.5033
3 THYMUS HYPOPLASIA 82 0.4713
4 OCCUPATIONAL ASTHMA 19 0.3276
5 PICORNAVIRUS INFECTION 14 0.3256
6 PERINEAL NECROSIS 13 0.3171
7 CYSTITIS BACTERIAL 107 0.3166
8 NOROVIRUS TEST POSITIVE 100 0.3077
9 MYCOBACTERIUM CHELONAE INFECTION 168 0.2273
10 SECONDARY IMMUNODEFICIENCY 250 0.2058
11 ABSCESS BACTERIAL 71 0.1956
12 HEPATOSPLENIC T-CELL LYMPHOMA 71 0.1914
13 FIBRINOUS BRONCHITIS 14 0.1842
14 ENTEROVIRUS TEST POSITIVE 26 0.1494
15 CORONA VIRUS INFECTION 62 0.1442
16 TREATMENT RELATED SECONDARY MALIGNANCY 24 0.1182
17 PARAINFLUENZAE VIRUS INFECTION 169 0.1110
18 PSEUDOMONAL SEPSIS 181 0.1033
19 GLIOMA 66 0.1026
20 CENTRAL HYPOTHYROIDISM 31 0.0937
21 EOSINOPHILIC PNEUMONIA CHRONIC 27 0.0909
22 HUMAN HERPESVIRUS 6 INFECTION 163 0.0862
23 EOSINOPHILIC BRONCHITIS 17 0.0850
24 BACTERIAL VULVOVAGINITIS 24 0.0830
25 ENTEROBACTER INFECTION 138 0.0820
26 TEMPORAL LOBE EPILEPSY 34 0.0778
27 HUMAN RHINOVIRUS TEST POSITIVE 29 0.0777
28 CYTOMEGALOVIRUS CHORIORETINITIS 137 0.0702
29 VIRAEMIA 96 0.0693
30 DISSEMINATED ASPERGILLOSIS 32 0.0678
31 PERINEAL INFECTION 13 0.0657
32 DIFFUSE ALVEOLAR DAMAGE 75 0.0652
33 ANTITHROMBIN III DECREASED 17 0.0623
34 T-CELL TYPE ACUTE LEUKAEMIA 12 0.0588
35 ENTEROVIRUS INFECTION 47 0.0544
36 GLIOBLASTOMA MULTIFORME 44 0.0523
37 BACILLUS INFECTION 33 0.0522
38 RHINOVIRUS INFECTION 202 0.0518
39 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 130 0.0503
40 PNEUMATOSIS INTESTINALIS 142 0.0497
41 ILEOCAECAL RESECTION 17 0.0494
42 OESOPHAGEAL DILATATION 21 0.0475
43 NODULAR REGENERATIVE HYPERPLASIA 29 0.0452
44 BILE ACID MALABSORPTION 12 0.0426
45 VITAL CAPACITY DECREASED 19 0.0424
46 LENTIGO 21 0.0423
47 ANGIOCENTRIC LYMPHOMA 20 0.0407
48 LEUKAEMIA RECURRENT 67 0.0396
49 TRICHODYSPLASIA SPINULOSA 15 0.0394
50 VENOOCCLUSIVE LIVER DISEASE 191 0.0386
51 GASTROENTERITIS NOROVIRUS 51 0.0384
52 GALLBLADDER OEDEMA 11 0.0375
53 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 11 0.0369
54 ENTEROBACTER BACTERAEMIA 11 0.0363
55 ANAEMIA MEGALOBLASTIC 16 0.0359
56 CAECITIS 16 0.0356
57 OTITIS MEDIA ACUTE 26 0.0353
58 MOLLUSCUM CONTAGIOSUM 19 0.0352
59 FEMALE STERILISATION 18 0.0350
60 MYELODYSPLASTIC SYNDROME TRANSFORMATION 18 0.0345
61 DRUG CLEARANCE DECREASED 45 0.0344
62 CROHN'S DISEASE 232 0.0338
63 HAEMOPHILUS INFECTION 33 0.0336
64 CENTRAL OBESITY 24 0.0325
65 CYTOMEGALOVIRUS HEPATITIS 11 0.0311
66 PSEUDOMONAL BACTERAEMIA 25 0.0293
67 FEBRILE NEUTROPENIA 1932 0.0291
68 CHLOROMA 12 0.0284
69 LOWER RESPIRATORY TRACT INFECTION FUNGAL 11 0.0283
70 CYTOMEGALOVIRUS VIRAEMIA 125 0.0281
71 ENTERITIS 173 0.0270
72 MINIMAL RESIDUAL DISEASE 13 0.0269
73 VENOOCCLUSIVE DISEASE 67 0.0267
74 GASTROINTESTINAL WALL THICKENING 40 0.0267
75 FAECAL CALPROTECTIN ABNORMAL 11 0.0265
76 EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER 13 0.0264
77 BRONCHOPULMONARY ASPERGILLOSIS 203 0.0262
78 LEUKOENCEPHALOPATHY 97 0.0260
79 OESOPHAGEAL CANDIDIASIS 102 0.0256
80 CLOSTRIDIUM DIFFICILE COLITIS 267 0.0252
81 INTESTINAL ANASTOMOSIS 16 0.0248
82 PULMONARY MUCORMYCOSIS 13 0.0246
83 PANCREATIC PSEUDOCYST 19 0.0245
84 VENOUS THROMBOSIS 96 0.0244
85 PSEUDOMONAS TEST POSITIVE 20 0.0244
86 ASPERGILLUS INFECTION 160 0.0244
87 SCEDOSPORIUM INFECTION 17 0.0241
88 HISTOPLASMOSIS DISSEMINATED 38 0.0239
89 ABDOMINAL COMPARTMENT SYNDROME 15 0.0235
90 HISTIOCYTOSIS HAEMATOPHAGIC 69 0.0232
91 FEBRILE BONE MARROW APLASIA 97 0.0228
92 DRUG LEVEL ABNORMAL 12 0.0226
93 SUPERIOR SAGITTAL SINUS THROMBOSIS 18 0.0225
94 HYPERTRIGLYCERIDAEMIA 132 0.0225
95 ILEAL STENOSIS 40 0.0225
96 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 39 0.0220
97 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 13 0.0220
98 PERIRECTAL ABSCESS 24 0.0216
99 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 15 0.0213
100 CYTOGENETIC ABNORMALITY 24 0.0213
101 TERMINAL ILEITIS 13 0.0212
102 BACTERIAL INFECTION 385 0.0206
103 ENTEROCOLITIS INFECTIOUS 19 0.0206
104 MUCORMYCOSIS 53 0.0204
105 RHONCHI 28 0.0203
106 INTRACARDIAC THROMBUS 61 0.0199
107 MYELOPATHY 37 0.0195
108 CARDIAC VENTRICULAR THROMBOSIS 25 0.0194
109 BLOOD CULTURE POSITIVE 58 0.0194
110 BLOOD FIBRINOGEN DECREASED 22 0.0193
111 CEREBRAL VENOUS SINUS THROMBOSIS 16 0.0189
112 VASCULAR ACCESS COMPLICATION 15 0.0185
113 METAPNEUMOVIRUS INFECTION 14 0.0179
114 STRESS URINARY INCONTINENCE 19 0.0177
115 ACUTE LYMPHOCYTIC LEUKAEMIA 50 0.0176
116 ESCHERICHIA TEST POSITIVE 21 0.0175
117 T-CELL LYMPHOMA 20 0.0175
118 NEUTROPENIC COLITIS 36 0.0174
119 HAEMATOTOXICITY 163 0.0171
120 TRACHEITIS 13 0.0171
121 HISTOPLASMOSIS 30 0.0169
122 KLEBSIELLA TEST POSITIVE 11 0.0169
123 INTRACRANIAL VENOUS SINUS THROMBOSIS 18 0.0168
124 CUSHINGOID 53 0.0165
125 POUCHITIS 14 0.0163
126 SINUSITIS FUNGAL 13 0.0162
127 PNEUMONIA FUNGAL 64 0.0162
128 KLEBSIELLA SEPSIS 18 0.0160
129 PERIPHERAL MOTOR NEUROPATHY 22 0.0157
130 STENOTROPHOMONAS INFECTION 21 0.0155
131 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 12 0.0153
132 RECTAL ABSCESS 25 0.0149
133 ESCHERICHIA BACTERAEMIA 34 0.0144
134 SMALL INTESTINAL STENOSIS 15 0.0141
135 HYPERBILIRUBINAEMIA 145 0.0140
136 GALLBLADDER ENLARGEMENT 15 0.0139
137 KLEBSIELLA BACTERAEMIA 13 0.0137
138 ACUTE PROMYELOCYTIC LEUKAEMIA 14 0.0136
139 CHRONIC HEPATITIS 11 0.0136
140 INTESTINAL DILATATION 18 0.0135
141 EPIDERMAL NECROSIS 13 0.0133
142 HYPOFIBRINOGENAEMIA 13 0.0131
143 SYSTEMIC MYCOSIS 15 0.0128
144 CLOSTRIDIUM TEST POSITIVE 28 0.0127
145 FISTULA DISCHARGE 16 0.0127
146 CYTOMEGALOVIRUS COLITIS 29 0.0126
147 STRONGYLOIDIASIS 20 0.0124
148 APLASIA 24 0.0122
149 B-CELL LYMPHOMA 41 0.0121
150 BILIRUBIN CONJUGATED INCREASED 28 0.0120
151 NEOPLASM RECURRENCE 40 0.0118
152 HERPES SIMPLEX 76 0.0117
153 PROCTITIS 31 0.0111
154 HEPATOTOXICITY 240 0.0108
155 STAPHYLOCOCCAL SEPSIS 53 0.0107
156 MULTIPLE-DRUG RESISTANCE 33 0.0106
157 LUNG OPACITY 28 0.0106
158 FEMALE GENITAL TRACT FISTULA 18 0.0105
159 ACUTE MYELOID LEUKAEMIA 164 0.0105
160 LARGE INTESTINAL STENOSIS 21 0.0105
161 NEUROTOXICITY 183 0.0104
162 ANAL ABSCESS 56 0.0104
163 PORTAL HYPERTENSION 32 0.0104
164 MYELOSUPPRESSION 372 0.0103
165 DRUG SPECIFIC ANTIBODY PRESENT 67 0.0103
166 NASAL SEPTUM DEVIATION 20 0.0102
167 SECOND PRIMARY MALIGNANCY 85 0.0102
168 ABSCESS INTESTINAL 22 0.0102
169 JUGULAR VEIN THROMBOSIS 18 0.0101
170 VOCAL CORD PARALYSIS 18 0.0100
171 PANCREATITIS NECROTISING 23 0.0100
172 ESCHERICHIA INFECTION 82 0.0100
173 LISTERIOSIS 11 0.0099
174 INTESTINAL FISTULA 14 0.0099
175 ANAL FISTULA 53 0.0099
176 EPSTEIN-BARR VIRAEMIA 11 0.0099
177 HAEMOLYTIC URAEMIC SYNDROME 23 0.0099
178 SOFT TISSUE INFECTION 18 0.0098
179 HEPATOSPLENOMEGALY 25 0.0097
180 VIRAL INFECTION 321 0.0096
181 CHRONIC SINUSITIS 36 0.0096
182 ENCEPHALITIS 66 0.0095
183 HYPOALBUMINAEMIA 74 0.0095
184 STAPHYLOCOCCAL BACTERAEMIA 41 0.0094
185 MYELODYSPLASTIC SYNDROME 135 0.0093
186 ESCHERICHIA SEPSIS 27 0.0093
187 PNEUMONIA KLEBSIELLA 17 0.0092
188 BACTERIAL SEPSIS 30 0.0092
189 NON-HODGKIN'S LYMPHOMA 12 0.0092
190 SYSTEMIC CANDIDA 23 0.0092
191 EPSTEIN-BARR VIRUS INFECTION 57 0.0091
192 PNEUMONIA VIRAL 29 0.0091
193 STAPHYLOCOCCUS TEST POSITIVE 19 0.0090
194 HEPATITIS E 14 0.0089
195 BONE MARROW FAILURE 179 0.0088
196 PAINFUL RESPIRATION 21 0.0087
197 SUPERINFECTION 13 0.0087
198 MUCOSAL INFLAMMATION 225 0.0086
199 PNEUMOCYSTIS JIROVECI PNEUMONIA 19 0.0085
200 COLECTOMY 48 0.0085
201 ASPERGILLOSIS 11 0.0084
202 PROCTALGIA 54 0.0084
203 KLEBSIELLA INFECTION 42 0.0083
204 GASTROINTESTINAL STOMA COMPLICATION 13 0.0083
205 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 12 0.0083
206 ERYTHEMA NODOSUM 29 0.0083
207 FAECAL CALPROTECTIN INCREASED 26 0.0082
208 OTITIS MEDIA 27 0.0082
209 INTRACRANIAL PRESSURE INCREASED 45 0.0081
210 MENINGITIS CRYPTOCOCCAL 14 0.0080
211 STEROID DIABETES 12 0.0080
212 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 60 0.0080
213 ADENOVIRUS INFECTION 23 0.0079
214 INTESTINAL STENOSIS 33 0.0078
215 PANCYTOPENIA 435 0.0078
216 BRONCHITIS CHRONIC 19 0.0078
217 LYMPHOPENIA 110 0.0078
218 PANCREATITIS ACUTE 171 0.0076
219 ABDOMINAL ADHESIONS 24 0.0076
220 COLITIS ULCERATIVE 334 0.0075
221 PNEUMOCYSTIS JIROVECII PNEUMONIA 75 0.0075
222 ILEOSTOMY 19 0.0074
223 ENTEROCOLITIS HAEMORRHAGIC 11 0.0074
224 HYPERTRANSAMINASAEMIA 51 0.0073
225 LUNG INFILTRATION 64 0.0072
226 CEREBRAL VENOUS THROMBOSIS 13 0.0072
227 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 36 0.0071
228 LARGE INTESTINAL ULCER 19 0.0070
229 HEPATIC FIBROSIS 24 0.0070
230 COAGULOPATHY 115 0.0069
231 ANAL FISSURE 37 0.0069
232 BLOOD IMMUNOGLOBULIN G DECREASED 17 0.0069
233 FISTULA 77 0.0068
234 CHOLANGITIS SCLEROSING 14 0.0068
235 LUNG CONSOLIDATION 19 0.0068
236 GASTROINTESTINAL OEDEMA 12 0.0068
237 ATRIAL THROMBOSIS 14 0.0068
238 NEUTROPHIL COUNT ABNORMAL 19 0.0067
239 PNEUMONIA CYTOMEGALOVIRAL 13 0.0067
240 SMALL INTESTINAL OBSTRUCTION 82 0.0067
241 PULMONARY HAEMORRHAGE 52 0.0066
242 PANNICULITIS 16 0.0066
243 ABSCESS LIMB 28 0.0066
244 CYTOMEGALOVIRUS INFECTION REACTIVATION 29 0.0066
245 ORAL HERPES 128 0.0066
246 DRUG LEVEL ABOVE THERAPEUTIC 30 0.0065
247 GLOSSITIS 23 0.0065
248 LYMPHOPROLIFERATIVE DISORDER 19 0.0065
249 ENTEROCOLITIS 37 0.0064
250 STEM CELL TRANSPLANT 16 0.0064
251 CARDIOTOXICITY 57 0.0064
252 STENOSIS 12 0.0064
253 AREFLEXIA 17 0.0064
254 FUNCTIONAL GASTROINTESTINAL DISORDER 22 0.0064
255 DIFFUSE LARGE B-CELL LYMPHOMA 49 0.0064
256 PARTIAL SEIZURES 33 0.0063
257 BACTERIAL TEST POSITIVE 14 0.0063
258 LOSS OF THERAPEUTIC RESPONSE 20 0.0063
259 EMBOLISM VENOUS 19 0.0063
260 BACTERAEMIA 74 0.0062
261 SKIN PAPILLOMA 25 0.0062
262 COLITIS 234 0.0062
263 CYTOMEGALOVIRUS TEST POSITIVE 11 0.0062
264 BLOOD BILIRUBIN INCREASED 166 0.0061
265 ANAEMIA MACROCYTIC 13 0.0061
266 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 58 0.0061
267 PSEUDOMONAS INFECTION 52 0.0061
268 METHAEMOGLOBINAEMIA 14 0.0060
269 LIPASE INCREASED 46 0.0060
270 RESPIRATORY SYNCYTIAL VIRUS INFECTION 52 0.0060
271 CYTOPENIA 73 0.0060
272 CLOSTRIDIAL INFECTION 20 0.0059
273 CORONAVIRUS INFECTION 39 0.0059
274 OSTEONECROSIS 192 0.0058
275 PERIPHERAL SENSORY NEUROPATHY 34 0.0058
276 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 16 0.0058
277 DIARRHOEA HAEMORRHAGIC 54 0.0058
278 BODY TEMPERATURE FLUCTUATION 12 0.0058
279 CYTOMEGALOVIRUS INFECTION 93 0.0056
280 FUNGAL INFECTION 186 0.0056
281 FACIAL PALSY 12 0.0056
282 PARAPLEGIA 16 0.0055
283 NASAL POLYPS 27 0.0055
284 SPUTUM DISCOLOURED 52 0.0055
285 INJECTION SITE PAPULE 25 0.0055
286 MALNUTRITION 61 0.0054
287 GASTROINTESTINAL INFLAMMATION 42 0.0054
288 PANCREATITIS 282 0.0053
289 OCULAR ICTERUS 23 0.0053
290 APPENDICITIS 48 0.0051
291 DRUG LEVEL DECREASED 52 0.0051
292 NEUTROPHIL COUNT DECREASED 208 0.0051
293 SERUM SICKNESS 14 0.0050
294 APLASTIC ANAEMIA 26 0.0050
295 SPLENOMEGALY 58 0.0049
296 BLOOD LACTIC ACID INCREASED 26 0.0049
297 CLOSTRIDIUM DIFFICILE INFECTION 107 0.0049
298 DRUG LEVEL BELOW THERAPEUTIC 27 0.0049
299 DEVICE RELATED INFECTION 75 0.0049
300 FACIAL PARESIS 17 0.0048
301 MELANOCYTIC NAEVUS 21 0.0048
302 POLYNEUROPATHY 57 0.0048
303 TYPE IV HYPERSENSITIVITY REACTION 13 0.0047
304 RHINITIS 38 0.0047
305 SEPTIC SHOCK 205 0.0047
306 NOCARDIOSIS 12 0.0047
307 RESPIRATORY DISTRESS 129 0.0047
308 BONE MARROW DISORDER 14 0.0046
309 LUPUS-LIKE SYNDROME 42 0.0046
310 HEPATIC STEATOSIS 86 0.0046
311 AMYLASE INCREASED 17 0.0046
312 HYPERAMMONAEMIA 23 0.0046
313 HYPOGAMMAGLOBULINAEMIA 30 0.0046
314 ENTEROCOCCAL INFECTION 22 0.0045
315 SEPSIS 503 0.0045
316 NEUTROPENIA 612 0.0045
317 MENINGITIS 30 0.0045
318 FREQUENT BOWEL MOVEMENTS 121 0.0045
319 ABDOMINAL TENDERNESS 22 0.0044
320 FURUNCLE 35 0.0044
321 ALANINE AMINOTRANSFERASE INCREASED 271 0.0044
322 ACUTE RESPIRATORY DISTRESS SYNDROME 78 0.0044
323 TRANSAMINASES INCREASED 98 0.0044
324 INFLAMMATORY BOWEL DISEASE 43 0.0044
325 HEMIPARESIS 74 0.0044
326 ATELECTASIS 42 0.0043
327 VIITH NERVE PARALYSIS 15 0.0043
328 MULTIPLE ORGAN DYSFUNCTION SYNDROME 123 0.0043
329 ABDOMINAL ABSCESS 19 0.0043
330 CANDIDIASIS 17 0.0042
331 SUBCUTANEOUS ABSCESS 20 0.0042
332 THERAPEUTIC REACTION TIME DECREASED 12 0.0041
333 CELLULITIS 204 0.0040
334 ILEUS PARALYTIC 18 0.0040
335 HYPOPHAGIA 103 0.0040
336 PROTHROMBIN TIME PROLONGED 24 0.0040
337 CHOLESTASIS 77 0.0040
338 IRON DEFICIENCY 18 0.0040
339 SQUAMOUS CELL CARCINOMA OF SKIN 24 0.0040
340 HEPATOMEGALY 39 0.0040
341 ENCEPHALOPATHY 96 0.0039
342 DEMYELINATION 16 0.0039
343 SKIN TOXICITY 22 0.0039
344 THROMBOCYTOSIS 14 0.0038
345 LEUKOPENIA 191 0.0038
346 HEPATITIS B REACTIVATION 12 0.0038
347 FACIAL PARALYSIS 32 0.0038
348 TACHYPNOEA 51 0.0037
349 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 19 0.0037
350 DEFAECATION URGENCY 26 0.0037
351 MULTI-ORGAN FAILURE 64 0.0037
352 ODYNOPHAGIA 22 0.0037
353 HYDROCEPHALUS 20 0.0037
354 APPENDICECTOMY 13 0.0036
355 PYODERMA GANGRENOSUM 13 0.0036
356 POTENTIATING DRUG INTERACTION 12 0.0036
357 BRAIN DEATH 11 0.0036
358 TOXIC ENCEPHALOPATHY 18 0.0035
359 DISSEMINATED INTRAVASCULAR COAGULATION 50 0.0035
360 FOOD INTOLERANCE 13 0.0035
361 CHOLANGITIS 22 0.0035
362 INTESTINAL RESECTION 19 0.0035
363 ESCHERICHIA URINARY TRACT INFECTION 15 0.0035
364 SINUS TACHYCARDIA 50 0.0035
365 CACHEXIA 18 0.0035
366 HYPERGLYCAEMIA 127 0.0035
367 CYSTITIS HAEMORRHAGIC 14 0.0035
368 ADRENAL INSUFFICIENCY 42 0.0035
369 PYREXIA 1192 0.0034
370 MUCOUS STOOLS 17 0.0034
371 DRUG-INDUCED LIVER INJURY 106 0.0034
372 PULSE ABSENT 16 0.0034
373 NEUTROPENIC SEPSIS 24 0.0034
374 MENTAL STATUS CHANGES 93 0.0033
375 POOR PERIPHERAL CIRCULATION 14 0.0033
376 BODY TEMPERATURE INCREASED 67 0.0033
377 ASPARTATE AMINOTRANSFERASE INCREASED 174 0.0033
378 ORAL DISORDER 24 0.0033
379 ABSCESS 52 0.0033
380 CANDIDA INFECTION 55 0.0033
381 STAPHYLOCOCCAL INFECTION 107 0.0032
382 STREPTOCOCCAL INFECTION 18 0.0032
383 PARONYCHIA 14 0.0032
384 HYPERURICAEMIA 13 0.0032
385 DRUG DELIVERY SYSTEM MALFUNCTION 16 0.0031
386 JAUNDICE CHOLESTATIC 11 0.0031
387 CHOLECYSTITIS 37 0.0031
388 ASCITES 91 0.0031
389 APHTHOUS ULCER 24 0.0031
390 EYE MOVEMENT DISORDER 21 0.0031
391 IMMUNOSUPPRESSION 27 0.0031
392 GRAFT VERSUS HOST DISEASE 22 0.0031
393 NECROSIS 17 0.0031
394 STOMATITIS 185 0.0030
395 PULMONARY TUBERCULOSIS 13 0.0030
396 SERUM FERRITIN INCREASED 16 0.0030
397 CHRONIC MYELOID LEUKAEMIA 14 0.0030
398 BLOOD ALBUMIN DECREASED 24 0.0030
399 ABDOMINAL PAIN 703 0.0030
400 CYSTITIS 96 0.0030
401 ACUTE HEPATIC FAILURE 41 0.0030
402 GASTROINTESTINAL MOTILITY DISORDER 16 0.0030
403 RECTAL HAEMORRHAGE 128 0.0030
404 VITAMIN B12 DEFICIENCY 12 0.0030
405 ORAL CANDIDIASIS 39 0.0030
406 VIRAL UPPER RESPIRATORY TRACT INFECTION 14 0.0029
407 THROMBOCYTOPENIA 329 0.0029
408 CYTOKINE RELEASE SYNDROME 58 0.0029
409 ANAL INCONTINENCE 26 0.0029
410 UPPER RESPIRATORY TRACT INFECTION 133 0.0029
411 BLOOD PRESSURE FLUCTUATION 69 0.0029
412 BLOOD DISORDER 23 0.0029
413 SQUAMOUS CELL CARCINOMA 27 0.0029
414 INTESTINAL OBSTRUCTION 108 0.0029
415 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 49 0.0029
416 TUMOUR LYSIS SYNDROME 25 0.0028
417 HYPOXIA 100 0.0028
418 FULL BLOOD COUNT ABNORMAL 30 0.0028
419 RESPIRATORY FAILURE 206 0.0028
420 JAUNDICE 76 0.0028
421 LUNG NEOPLASM 12 0.0028
422 HEPATIC ENZYME ABNORMAL 14 0.0028
423 METASTASIS 20 0.0028
424 DERMATITIS ACNEIFORM 17 0.0028
425 PETECHIAE 29 0.0028
426 HEPATIC LESION 12 0.0028
427 METABOLIC DISORDER 16 0.0028
428 AMMONIA INCREASED 14 0.0027
429 HYPOGLYCAEMIA 133 0.0027
430 GASTROENTERITIS 40 0.0027
431 PLATELET COUNT DECREASED 289 0.0027
432 TONSILLITIS 14 0.0027
433 HAEMATOCHEZIA 147 0.0027
434 LYMPHOCYTE COUNT DECREASED 47 0.0027
435 PERONEAL NERVE PALSY 15 0.0026
436 ACIDOSIS 20 0.0026
437 TACHYCARDIA 232 0.0026
438 HEPATIC CYTOLYSIS 33 0.0026
439 GAMMA-GLUTAMYLTRANSFERASE INCREASED 57 0.0026
440 HYPOPHOSPHATAEMIA 19 0.0026
441 DRUG TOXICITY 35 0.0026
442 ATAXIA 30 0.0025
443 CEREBRAL ISCHAEMIA 13 0.0025
444 ELECTROLYTE IMBALANCE 29 0.0025
445 ANAEMIA 475 0.0025
446 DRUG LEVEL INCREASED 41 0.0025
447 THERAPY NON-RESPONDER 111 0.0025
448 LYMPHADENOPATHY 87 0.0025
449 GASTROINTESTINAL INFECTION 22 0.0025
450 LARGE INTESTINE POLYP 17 0.0025
451 LARGE INTESTINE PERFORATION 17 0.0024
452 SHOCK 56 0.0024
453 HEPATIC FAILURE 73 0.0024
454 GASTROINTESTINAL SOUNDS ABNORMAL 12 0.0024
455 CHEILITIS 13 0.0024
456 THERAPEUTIC PRODUCT EFFECT DECREASED 107 0.0024
457 UROSEPSIS 22 0.0024
458 BLOOD PRESSURE DIASTOLIC INCREASED 11 0.0024
459 CARDIOMYOPATHY 35 0.0024
460 SARS-COV-2 TEST POSITIVE 31 0.0023
461 ENDOCARDITIS 12 0.0023
462 DYSARTHRIA 88 0.0023
463 BODY TEMPERATURE DECREASED 23 0.0023
464 ILEUS 29 0.0023
465 LEUKAEMIA 22 0.0023
466 MYOPATHY 20 0.0023
467 INFUSION RELATED REACTION 153 0.0023
468 BASAL CELL CARCINOMA 36 0.0023
469 FAECAL INCONTINENCE 11 0.0023
470 EMBOLISM 19 0.0023
471 GRANULOCYTOPENIA 13 0.0023
472 RHINORRHOEA 147 0.0023
473 PNEUMOTHORAX 36 0.0023
474 PULMONARY TOXICITY 16 0.0023
475 BLOOD COUNT ABNORMAL 34 0.0022
476 PALLOR 61 0.0022
477 PLEURAL EFFUSION 136 0.0022
478 POSTOPERATIVE WOUND INFECTION 15 0.0022
479 INFLAMMATORY MARKER INCREASED 11 0.0022
480 PERICARDIAL EFFUSION 51 0.0022
481 INJECTION SITE HAEMATOMA 32 0.0022
482 FLUID INTAKE REDUCED 11 0.0022
483 PATHOGEN RESISTANCE 20 0.0022
484 LIVER FUNCTION TEST INCREASED 47 0.0022
485 LUNG INFECTION 34 0.0022
486 POST PROCEDURAL COMPLICATION 42 0.0022
487 WHITE BLOOD CELL COUNT DECREASED 237 0.0022
488 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 22 0.0021
489 HERPES ZOSTER 123 0.0021
490 LOW BIRTH WEIGHT BABY 17 0.0021
491 INTESTINAL PERFORATION 24 0.0021
492 PHARYNGITIS STREPTOCOCCAL 23 0.0021
493 DISEASE RECURRENCE 101 0.0021
494 BLOOD IRON DECREASED 25 0.0021
495 HYPOTONIA 21 0.0021
496 NEUROPATHY PERIPHERAL 198 0.0021
497 ABNORMAL FAECES 17 0.0021
498 ORAL PAIN 46 0.0021
499 UNRESPONSIVE TO STIMULI 53 0.0021
500 THERAPY PARTIAL RESPONDER 32 0.0020
501 HEPATIC ENCEPHALOPATHY 19 0.0020
502 HAEMOGLOBIN DECREASED 209 0.0020
503 SUBDURAL HAEMATOMA 29 0.0020
504 EOSINOPHILIA 35 0.0020
505 PLATELET COUNT ABNORMAL 12 0.0020
506 OBSTRUCTIVE AIRWAYS DISORDER 22 0.0020
507 FOETAL GROWTH RESTRICTION 12 0.0020
508 EYELID PTOSIS 20 0.0020
509 NEPHROPATHY TOXIC 22 0.0020
510 IRON DEFICIENCY ANAEMIA 18 0.0019
511 IMPAIRED QUALITY OF LIFE 28 0.0019
512 PIGMENTATION DISORDER 12 0.0019
513 CHOLECYSTITIS ACUTE 11 0.0019
514 POOR VENOUS ACCESS 20 0.0019
515 BRONCHIECTASIS 13 0.0019
516 NEUROLOGICAL SYMPTOM 11 0.0019
517 BLOOD TRIGLYCERIDES INCREASED 34 0.0019
518 ACUTE RESPIRATORY FAILURE 37 0.0019
519 CHOLELITHIASIS 63 0.0019
520 INFLAMMATION 99 0.0019
521 RESPIRATORY RATE INCREASED 17 0.0019
522 AUTOIMMUNE HEPATITIS 13 0.0019
523 CHILLS 219 0.0019
524 INJECTION SITE EXTRAVASATION 23 0.0019
525 DECREASED ACTIVITY 20 0.0019
526 PNEUMONIA BACTERIAL 17 0.0019
527 DERMATITIS CONTACT 21 0.0018
528 GRAND MAL CONVULSION 17 0.0018
529 HYPERLIPIDAEMIA 22 0.0018
530 HEPATITIS 47 0.0018
531 HEPATITIS CHOLESTATIC 11 0.0018
532 INFECTION 264 0.0018
533 ABDOMINAL PAIN LOWER 46 0.0018
534 LYMPHOMA 28 0.0018
535 RESPIRATORY TRACT INFECTION 47 0.0018
536 LEFT VENTRICULAR DYSFUNCTION 12 0.0018
537 LIVER FUNCTION TEST ABNORMAL 52 0.0018
538 INTENTIONAL PRODUCT USE ISSUE 156 0.0018
539 PRODUCTIVE COUGH 85 0.0018
540 COVID-19 PNEUMONIA 21 0.0018
541 TREATMENT FAILURE 147 0.0018
542 MOUTH HAEMORRHAGE 13 0.0018
543 HEPATIC FUNCTION ABNORMAL 66 0.0018
544 OROPHARYNGEAL PAIN 163 0.0018
545 MOUTH ULCERATION 37 0.0018
546 HYPOKALAEMIA 81 0.0018
547 DRUG INTOLERANCE 169 0.0017
548 EJECTION FRACTION DECREASED 27 0.0017
549 SKIN LESION 47 0.0017
550 DRUG RESISTANCE 44 0.0017
551 FLANK PAIN 16 0.0017
552 ANAPHYLACTIC REACTION 94 0.0017
553 PROCEDURAL COMPLICATION 13 0.0017
554 HEPATOCELLULAR INJURY 24 0.0017
555 GENERALISED TONIC-CLONIC SEIZURE 28 0.0017
556 HAEMOLYSIS 13 0.0017
557 HAEMOLYTIC ANAEMIA 15 0.0017
558 HAEMODIALYSIS 14 0.0017
559 HAEMATOCRIT DECREASED 33 0.0017
560 SEIZURE 192 0.0017
561 NEUTROPHIL COUNT INCREASED 17 0.0017
562 THROMBOTIC MICROANGIOPATHY 16 0.0016
563 NO THERAPEUTIC RESPONSE 20 0.0016
564 CEREBRAL INFARCTION 40 0.0016
565 PNEUMONIA 529 0.0016
566 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 38 0.0016
567 LIVER INJURY 40 0.0016
568 BLOOD PRESSURE DIASTOLIC DECREASED 12 0.0016
569 SEASONAL ALLERGY 23 0.0016
570 HEART RATE DECREASED 57 0.0016
571 VOMITING 761 0.0016
572 GASTROENTERITIS VIRAL 29 0.0016
573 JOINT EFFUSION 11 0.0016
574 C-REACTIVE PROTEIN INCREASED 58 0.0016
575 TOOTH ABSCESS 16 0.0016
576 GLAUCOMA 30 0.0016
577 GASTROINTESTINAL DISORDER 139 0.0016
578 UVEITIS 21 0.0015
579 GASTROINTESTINAL PAIN 17 0.0015
580 PNEUMONITIS 42 0.0015
581 HYPOCALCAEMIA 29 0.0015
582 BLOOD ALKALINE PHOSPHATASE INCREASED 38 0.0015
583 SKIN INFECTION 17 0.0015
584 FAECES SOFT 11 0.0015
585 HYPOMAGNESAEMIA 21 0.0015
586 INJECTION SITE URTICARIA 37 0.0015
587 DRUG INTERACTION 239 0.0015
588 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 82 0.0015
589 CONDITION AGGRAVATED 454 0.0015
590 INJECTION SITE IRRITATION 19 0.0015
591 MALIGNANT MELANOMA 20 0.0015
592 URINE OUTPUT DECREASED 13 0.0015
593 HAEMORRHOIDS 29 0.0015
594 PULMONARY MASS 22 0.0015
595 INTERNATIONAL NORMALISED RATIO INCREASED 42 0.0015
596 SUBARACHNOID HAEMORRHAGE 15 0.0015
597 METABOLIC ACIDOSIS 47 0.0015
598 OESOPHAGITIS 16 0.0015
599 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 103 0.0014
600 NASAL CONGESTION 85 0.0014
601 VENTRICULAR EXTRASYSTOLES 15 0.0014
602 NEURALGIA 35 0.0014
603 OSTEOMYELITIS 26 0.0014
604 BLOOD POTASSIUM DECREASED 43 0.0014
605 MUSCULAR WEAKNESS 162 0.0014
606 APHASIA 43 0.0014
607 MUSCULOSKELETAL CHEST PAIN 22 0.0014
608 HYPOTENSION 284 0.0014
609 BLOOD PRESSURE ABNORMAL 28 0.0014
610 DEEP VEIN THROMBOSIS 91 0.0014
611 FLUID OVERLOAD 20 0.0014
612 EPILEPSY 42 0.0014
613 TOOTH INFECTION 18 0.0014
614 CONVULSION 78 0.0014
615 EPISTAXIS 101 0.0013
616 DEHYDRATION 180 0.0013
617 WHEEZING 80 0.0013
618 BRAIN OEDEMA 17 0.0013
619 NERVOUS SYSTEM DISORDER 42 0.0013
620 TENDERNESS 14 0.0013
621 CARDIO-RESPIRATORY ARREST 56 0.0013
622 DIALYSIS 19 0.0013
623 HAEMORRHAGE INTRACRANIAL 20 0.0013
624 TRANSFUSION 14 0.0013
625 DYSPNOEA EXERTIONAL 50 0.0013
626 HAEMOPTYSIS 37 0.0013
627 HEPATIC ENZYME INCREASED 90 0.0013
628 ACUTE KIDNEY INJURY 201 0.0013
629 OFF LABEL USE 1150 0.0013
630 ABDOMINAL DISTENSION 137 0.0013
631 COUGH 368 0.0013
632 WHITE BLOOD CELL COUNT INCREASED 49 0.0013
633 PHOTOPHOBIA 24 0.0013
634 INJECTION SITE NODULE 14 0.0013
635 MUSCLE STRAIN 11 0.0013
636 LETHARGY 73 0.0013
637 SKIN CANCER 27 0.0013
638 OSTEOPENIA 19 0.0013
639 FOLLICULITIS 13 0.0012
640 STATUS EPILEPTICUS 14 0.0012
641 AGRANULOCYTOSIS 23 0.0012
642 PLATELET COUNT INCREASED 16 0.0012
643 HEPATIC CIRRHOSIS 23 0.0012
644 HAEMATEMESIS 31 0.0012
645 INTERSTITIAL LUNG DISEASE 59 0.0012
646 LIGAMENT SPRAIN 12 0.0012
647 NIGHT SWEATS 39 0.0012
648 SINUSITIS 124 0.0012
649 OVARIAN CYST 12 0.0012
650 RED BLOOD CELL SEDIMENTATION RATE INCREASED 13 0.0012
651 OXYGEN SATURATION DECREASED 66 0.0012
652 RIB FRACTURE 24 0.0012
653 LEUKOCYTOSIS 21 0.0012
654 RASH PAPULAR 26 0.0012
655 WRONG TECHNIQUE IN DRUG USAGE PROCESS 42 0.0012
656 NEPHROLITHIASIS 53 0.0012
657 EYE INFECTION 13 0.0012
658 HEART RATE IRREGULAR 26 0.0011
659 THERAPEUTIC RESPONSE SHORTENED 38 0.0011
660 TOXICITY TO VARIOUS AGENTS 193 0.0011
661 CHOLECYSTECTOMY 13 0.0011
662 BLOOD LACTATE DEHYDROGENASE INCREASED 18 0.0011
663 BLOOD UREA INCREASED 19 0.0011
664 MYOCARDITIS 13 0.0011
665 BRADYCARDIA 60 0.0011
666 RED BLOOD CELL COUNT DECREASED 32 0.0011
667 CIRCULATORY COLLAPSE 19 0.0011
668 GASTROINTESTINAL HAEMORRHAGE 93 0.0011
669 DIARRHOEA 705 0.0011
670 PHOTOSENSITIVITY REACTION 18 0.0011
671 HERNIA 21 0.0011
672 LACTIC ACIDOSIS 35 0.0011
673 EAR PAIN 21 0.0011
674 URINARY INCONTINENCE 32 0.0011
675 IMMUNODEFICIENCY 16 0.0011
676 PULMONARY OEDEMA 48 0.0011
677 HAEMORRHAGE 112 0.0011
678 RESPIRATORY TRACT CONGESTION 17 0.0011
679 GALLBLADDER DISORDER 19 0.0011
680 CEREBRAL HAEMORRHAGE 38 0.0011
681 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 18 0.0011
682 BLOOD CREATININE INCREASED 69 0.0011
683 INJECTION SITE HAEMORRHAGE 84 0.0011
684 DERMATITIS 22 0.0010
685 PREGNANCY 21 0.0010
686 COVID-19 183 0.0010
687 ABORTION SPONTANEOUS 41 0.0010
688 BACK PAIN 237 0.0010
689 NECK PAIN 57 0.0010
690 TUBULOINTERSTITIAL NEPHRITIS 19 0.0010
691 NAUSEA 800 0.0010
692 INJECTION SITE RASH 31 0.0010
693 SINUS DISORDER 20 0.0010
694 BLOOD PRESSURE DECREASED 67 0.0010
695 INJECTION SITE PAIN 309 0.0010
696 INJECTION SITE PRURITUS 66 0.0010
697 PRODUCT USE IN UNAPPROVED INDICATION 244 0.0010
698 IRRITABLE BOWEL SYNDROME 21 0.0010
699 DECREASED APPETITE 226 0.0010
700 BRONCHITIS 72 0.0010
701 LIVER DISORDER 43 0.0010
702 PHARYNGITIS 12 0.0010
703 RENAL IMPAIRMENT 81 0.0010
704 SINUS CONGESTION 13 0.0010
705 HEADACHE 603 0.0010
706 WEIGHT DECREASED 267 0.0010
707 PAIN IN JAW 27 0.0010
708 HEART RATE INCREASED 94 0.0009
709 PULMONARY EMBOLISM 90 0.0009
710 BONE DISORDER 17 0.0009
711 DIPLOPIA 24 0.0009
712 DELIRIUM 32 0.0009
713 BONE PAIN 54 0.0009
714 ORTHOSTATIC HYPOTENSION 16 0.0009
715 LOCAL SWELLING 16 0.0009
716 CONJUNCTIVITIS 17 0.0009
717 DISEASE PROGRESSION 108 0.0009
718 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 164 0.0009
719 ARTHRALGIA 377 0.0009
720 EAR INFECTION 24 0.0009
721 SKIN DISORDER 30 0.0009
722 JOINT RANGE OF MOTION DECREASED 12 0.0009
723 CYANOSIS 14 0.0009
724 INCREASED APPETITE 17 0.0009
725 FACE OEDEMA 15 0.0009
726 CHROMATURIA 20 0.0009
727 WEIGHT INCREASED 198 0.0009
728 DRUG EXPOSURE DURING PREGNANCY 30 0.0009
729 ABDOMINAL PAIN UPPER 181 0.0009
730 LUNG DISORDER 43 0.0009
731 MUSCULOSKELETAL DISCOMFORT 15 0.0009
732 INFLUENZA 97 0.0009
733 THROAT IRRITATION 39 0.0009
734 KIDNEY INFECTION 17 0.0009
735 HYPERTENSION 183 0.0009
736 NEOPLASM PROGRESSION 30 0.0009
737 DYSKINESIA 35 0.0009
738 SWELLING FACE 56 0.0009
739 WOUND 24 0.0009
740 RENAL FAILURE 114 0.0009
741 CARPAL TUNNEL SYNDROME 12 0.0009
742 DRUG DISPENSING ERROR 13 0.0008
743 INJECTION SITE INDURATION 11 0.0008
744 RENAL FAILURE ACUTE 36 0.0008
745 HAEMATURIA 29 0.0008
746 HYPOTHYROIDISM 27 0.0008
747 DRUG INEFFECTIVE 1108 0.0008
748 URINARY RETENTION 28 0.0008
749 INCORRECT DOSE ADMINISTERED 191 0.0008
750 CARDIAC ARREST 69 0.0008
751 RESPIRATORY DISORDER 25 0.0008
752 DEPRESSED LEVEL OF CONSCIOUSNESS 33 0.0008
753 SYNOVITIS 15 0.0008
754 ALTERED STATE OF CONSCIOUSNESS 18 0.0008
755 MATERNAL EXPOSURE DURING PREGNANCY 74 0.0008
756 TOOTHACHE 15 0.0008
757 FEELING COLD 23 0.0008
758 SCAR 14 0.0008
759 DRUG EFFECT DECREASED 44 0.0008
760 RASH ERYTHEMATOUS 39 0.0008
761 MEDICATION ERROR 45 0.0008
762 INJECTION SITE ERYTHEMA 100 0.0008
763 PRODUCT USE ISSUE 151 0.0008
764 CONSTIPATION 175 0.0008
765 OSTEOPOROSIS 33 0.0008
766 CHEST PAIN 148 0.0008
767 HYPONATRAEMIA 45 0.0008
768 HYPERSENSITIVITY 148 0.0008
769 BLOOD SODIUM DECREASED 15 0.0008
770 GASTROOESOPHAGEAL REFLUX DISEASE 64 0.0008
771 PARAESTHESIA 125 0.0008
772 PROCEDURAL PAIN 22 0.0008
773 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 38 0.0008
774 INJECTION SITE BRUISING 63 0.0008
775 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 56 0.0008
776 BLOOD PRESSURE INCREASED 118 0.0008
777 BRONCHOSPASM 11 0.0008
778 PAIN IN EXTREMITY 225 0.0008
779 JOINT STIFFNESS 20 0.0008
780 HYPOAESTHESIA 114 0.0008
781 GASTRITIS 20 0.0008
782 ULCER 12 0.0008
783 GENERAL PHYSICAL HEALTH DETERIORATION 87 0.0008
784 ASTHENIA 282 0.0007
785 SYNCOPE 75 0.0007
786 SENSORY DISTURBANCE 12 0.0007
787 OEDEMA PERIPHERAL 91 0.0007
788 THERAPEUTIC RESPONSE DECREASED 45 0.0007
789 EXPOSURE DURING PREGNANCY 46 0.0007
790 THROAT TIGHTNESS 20 0.0007
791 FAECES DISCOLOURED 16 0.0007
792 THERAPEUTIC RESPONSE UNEXPECTED 33 0.0007
793 DYSURIA 27 0.0007
794 INJECTION SITE SWELLING 56 0.0007
795 CONTUSION 70 0.0007
796 VENTRICULAR TACHYCARDIA 12 0.0007
797 PERITONITIS 15 0.0007
798 DYSSTASIA 21 0.0007
799 FEELING HOT 44 0.0007
800 NASOPHARYNGITIS 132 0.0007
801 FATIGUE 556 0.0007
802 ARTHRITIS 56 0.0007
803 RASH 309 0.0007
804 THROMBOSIS 57 0.0007
805 OEDEMA 38 0.0007
806 PSORIASIS 91 0.0007
807 DYSPHAGIA 66 0.0007
808 CATARACT 41 0.0007
809 DRUG EFFECT INCOMPLETE 25 0.0007
810 MALAISE 301 0.0007
811 URINARY TRACT INFECTION 117 0.0007
812 PULMONARY FIBROSIS 13 0.0007
813 GOUT 12 0.0007
814 MUSCULOSKELETAL PAIN 35 0.0007
815 ADVERSE DRUG REACTION 60 0.0007
816 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
817 SLEEP DISORDER 47 0.0007
818 LOCALISED INFECTION 16 0.0007
819 TYPE 2 DIABETES MELLITUS 22 0.0007
820 DIVERTICULITIS 18 0.0006
821 RASH PRURITIC 35 0.0006
822 GAIT DISTURBANCE 123 0.0006
823 MYALGIA 109 0.0006
824 IMPAIRED HEALING 21 0.0006
825 ELECTROCARDIOGRAM QT PROLONGED 23 0.0006
826 MELAENA 14 0.0006
827 LOSS OF CONSCIOUSNESS 81 0.0006
828 INJECTION SITE WARMTH 13 0.0006
829 PREMATURE BABY 19 0.0006
830 AMENORRHOEA 11 0.0006
831 CHEST DISCOMFORT 64 0.0006
832 DIABETIC KETOACIDOSIS 15 0.0006
833 DEVICE ISSUE 56 0.0006
834 HYPERHIDROSIS 80 0.0006
835 EYE SWELLING 23 0.0006
836 LABORATORY TEST ABNORMAL 18 0.0006
837 INFLUENZA LIKE ILLNESS 50 0.0006
838 MUSCLE TWITCHING 14 0.0006
839 POOR QUALITY SLEEP 13 0.0006
840 FLUSHING 61 0.0006
841 FULL BLOOD COUNT DECREASED 12 0.0006
842 UNEVALUABLE EVENT 45 0.0006
843 LOWER RESPIRATORY TRACT INFECTION 27 0.0006
844 DYSPNOEA 334 0.0006
845 MIDDLE INSOMNIA 11 0.0006
846 FLATULENCE 33 0.0006
847 INJECTION SITE REACTION 40 0.0006
848 BLOOD CHOLESTEROL INCREASED 27 0.0006
849 RASH MACULAR 20 0.0006
850 DYSTONIA 11 0.0006
851 FOETAL EXPOSURE DURING PREGNANCY 46 0.0006
852 EATING DISORDER 12 0.0006
853 IMPAIRED WORK ABILITY 12 0.0006
854 AGITATION 41 0.0006
855 ABNORMAL BEHAVIOUR 22 0.0006
856 DEVICE MALFUNCTION 39 0.0006
857 ACNE 42 0.0006
858 SPEECH DISORDER 29 0.0006
859 PRODUCT PRESCRIBING ISSUE 12 0.0006
860 ALOPECIA 108 0.0005
861 IRRITABILITY 33 0.0005
862 CARDIAC FAILURE 44 0.0005
863 OSTEOARTHRITIS 23 0.0005
864 VISUAL ACUITY REDUCED 18 0.0005
865 PSYCHOTIC DISORDER 16 0.0005
866 SNEEZING 12 0.0005
867 TREMOR 88 0.0005
868 TREATMENT NONCOMPLIANCE 29 0.0005
869 OCULAR HYPERAEMIA 25 0.0005
870 ABASIA 13 0.0005
871 HYPERSOMNIA 15 0.0005
872 MUSCULOSKELETAL STIFFNESS 45 0.0005
873 URTICARIA 86 0.0005
874 SURGERY 30 0.0005
875 MOBILITY DECREASED 36 0.0005
876 MOVEMENT DISORDER 16 0.0005
877 MENTAL IMPAIRMENT 12 0.0005
878 PRESYNCOPE 12 0.0005
879 COGNITIVE DISORDER 23 0.0005
880 FLUID RETENTION 25 0.0005
881 CONFUSIONAL STATE 79 0.0005
882 ERYTHEMA 100 0.0005
883 HYPERKALAEMIA 17 0.0005
884 BLISTER 27 0.0005
885 PAIN 295 0.0005
886 GAIT INABILITY 16 0.0005
887 SKIN DISCOLOURATION 22 0.0005
888 VISION BLURRED 65 0.0005
889 DRUG DOSE OMISSION 78 0.0005
890 DIZZINESS 234 0.0005
891 JOINT SWELLING 56 0.0005
892 VERTIGO 28 0.0005
893 DIABETES MELLITUS 35 0.0005
894 MIGRAINE 42 0.0004
895 BLOOD GLUCOSE DECREASED 21 0.0004
896 MUSCLE SPASMS 80 0.0004
897 ABDOMINAL DISCOMFORT 73 0.0004
898 LACRIMATION INCREASED 13 0.0004
899 RENAL DISORDER 20 0.0004
900 DISORIENTATION 17 0.0004
901 ANAPHYLACTIC SHOCK 11 0.0004
902 ECZEMA 22 0.0004
903 LIP SWELLING 14 0.0004
904 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
905 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
906 ASTHMA 46 0.0004
907 THERAPY INTERRUPTED 29 0.0004
908 BALANCE DISORDER 35 0.0004
909 PALPITATIONS 47 0.0004
910 AMNESIA 26 0.0004
911 DYSPEPSIA 39 0.0004
912 SYSTEMIC LUPUS ERYTHEMATOSUS 14 0.0004
913 SOMNOLENCE 79 0.0004
914 LIMB DISCOMFORT 12 0.0004
915 UNDERDOSE 28 0.0004
916 ANXIETY 108 0.0004
917 HEAD INJURY 12 0.0004
918 PRURITUS 145 0.0004
919 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 11 0.0004
920 DEPRESSION 85 0.0004
921 HIP FRACTURE 12 0.0004
922 EYE PAIN 21 0.0004
923 SUICIDAL IDEATION 34 0.0004
924 OESOPHAGEAL CARCINOMA 11 0.0004
925 BURNING SENSATION 26 0.0004
926 THERAPY CESSATION 19 0.0004
927 FALL 121 0.0004
928 MALIGNANT NEOPLASM PROGRESSION 37 0.0004
929 ARTHROPATHY 20 0.0004
930 POLLAKIURIA 15 0.0004
931 ADVERSE EVENT 33 0.0004
932 EYE PRURITUS 12 0.0004
933 DEATH 303 0.0004
934 BLINDNESS 14 0.0003
935 CEREBROVASCULAR ACCIDENT 58 0.0003
936 AGGRESSION 17 0.0003
937 ANGIOEDEMA 15 0.0003
938 RHABDOMYOLYSIS 14 0.0003
939 FEELING ABNORMAL 79 0.0003
940 ILLNESS 33 0.0003
941 HOT FLUSH 24 0.0003
942 INSOMNIA 84 0.0003
943 INJURY 22 0.0003
944 INTENTIONAL PRODUCT MISUSE 27 0.0003
945 TINNITUS 14 0.0003
946 CHRONIC KIDNEY DISEASE 23 0.0003
947 CRYING 11 0.0003
948 ACCIDENTAL OVERDOSE 11 0.0003
949 NEOPLASM MALIGNANT 20 0.0003
950 HOSPITALISATION 46 0.0003
951 ILL-DEFINED DISORDER 18 0.0003
952 DEPRESSED MOOD 15 0.0003
953 HALLUCINATION 21 0.0003
954 DISCOMFORT 17 0.0003
955 SWELLING 26 0.0003
956 ATRIAL FIBRILLATION 27 0.0003
957 COMA 13 0.0003
958 DYSGEUSIA 20 0.0003
959 DYSPHONIA 15 0.0003
960 MENTAL DISORDER 11 0.0003
961 MYOCARDIAL INFARCTION 44 0.0003
962 DRY MOUTH 20 0.0002
963 DRY EYE 12 0.0002
964 PERIPHERAL SWELLING 37 0.0002
965 CARDIAC FAILURE CONGESTIVE 19 0.0002
966 OVERDOSE 51 0.0002
967 PRODUCT DOSE OMISSION ISSUE 69 0.0002
968 COLORECTAL CANCER 11 0.0002
969 SKIN EXFOLIATION 18 0.0002
970 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
971 DERMATITIS ATOPIC 11 0.0002
972 DISTURBANCE IN ATTENTION 11 0.0002
973 MEMORY IMPAIRMENT 28 0.0002
974 BLOOD GLUCOSE INCREASED 38 0.0002
975 PRODUCT DOSE OMISSION 13 0.0002
976 COMPLETED SUICIDE 16 0.0002
977 PROSTATE CANCER 15 0.0002
978 PRODUCT STORAGE ERROR 16 0.0002
979 BREAST CANCER 17 0.0002
980 VISUAL IMPAIRMENT 22 0.0002
981 INTENTIONAL OVERDOSE 11 0.0002
982 DRY SKIN 20 0.0001
983 CARDIAC DISORDER 14 0.0001
984 PRODUCT QUALITY ISSUE 18 0.0001
985 NO ADVERSE EVENT 24 0.0001
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 24 0.0001
987 EMOTIONAL DISTRESS 13 0.0001
988 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
989 RHEUMATOID ARTHRITIS 12 0.0001
990 DRUG DEPENDENCE 12 0.0001